- Director of the Institute of Toxicology and Pharmacology at the University of Rostock
- Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
“Cannabinoids, in addition to having palliative benefits in cancer therapy, have been associated with anticarcinogenic effects. Cannabinoids may… offer a therapeutic option in the treatment of highly invasive cancers.”
“Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1”, Journal of the National Cancer Institute, Dec. 25, 2007
- Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
- Involvement and Affiliations:
- Director, Institute of Toxicology and Pharmacology, University of Rostock
- Former Researcher, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg
- PhD, school unknown
- None found